Patient Centric Field Quadruples Enrollment Increases
Regulatory environment can help support sponsors with the complex efforts involved in pediatric oncology drug development, as regulatory agencies and legislative....
ALZEVIT Study – RCB No.: 2026-A00246-45
Decentralised national digital cohort for APOE genotyping and longitudinal characterisation of APOE ε4/ε4 homozygote trajectories, with a view to developing strategies for Alzheimer's disease.
Decentralised national digital cohort for APOE genotyping and longitudinal characterisation of APOE ε4/ε4 homozygote trajectories, with a view to developing strategies for Alzheimer's disease.
Quick Contact
If you have any questions or need assistance, please do not hesitate to contact our team.
Send us an email :
Contact us by phone :
©2025 ALZEVIT, All Rights Reserved.